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Accepted 14 July 2014Obesity increases the risk for cardiomyopathy in the absence of comorbidities. Myocardial
structure is modified by dietary fatty acids. Left ventricular hypertrophy is associated with
Western (WES) diet consumption, whereas intake of n-3 polyunsaturated fatty acids is
associated with antihypertrophic effects. We previously observed no attenuation of left
ventricular thickening after 3 months of docosahexaenoic acid (DHA) supplementation of a
WES diet, compared with WES diet intake alone, in rats that had similar weight, adiposity,
and insulin sensitivity to control animals. The objective of this study was to define left
ventricular gene expression in these animals to determine whether diet alone was
associated with a physiologic or pathologic hypertrophic response. We hypothesized that
WES diet consumptionwould favor a pathologic ormaladaptivemyocardial gene expression
pattern and that DHA supplementation would favor a physiologic or adaptive response.
Microarray analysis identified 64 transcripts that were differentially expressed (P ≤ .001)
within one or more treatment comparisons. Using quantitative real-time polymerase chain
reaction, 29 genes with fold change at least 1.74 were successfully validated; all but 3 had
similar directionality to that observed using microarray, and 2 genes, connective tissue growth
factor and cathepsin M, were differentially expressed according to diet. WES blot analysis was
performed on 4 proteins relevant to myocardial hypertrophy and metabolism. Acyl-CoA
thioesterase 1, B-cell translocation gene 2, and carbonic anhydrase III showed directional
change consistent with gene expression. Retinol saturase (all-trans-retinol 13,14-reductase),
although not consistent with gene expression, was different according to diet, with
increased concentrations in WES-fed rats compared with control and DHA-supplemented
animals. Diet did not distinguish a transcriptome reflecting physiologic or pathologic
myocardial hypertrophy; furthermore, the modest changes observed suggest that obesityKeywords:
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composition in development of cardiomyopathy.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Dietary composition impactsmyocardial structureand function.
Intake of a “Western (WES)” diet rich in saturated fatty acids and
simple carbohydrates is associated with left ventricular hyper-
trophy (LVH) and diastolic dysfunction [1-3]. In contrast,
consumption of n-3 polyunsaturated fatty acids (PUFA) is
associated with antihypertrophic effects [4-7]. We were there-
fore surprised to observe that rats fed aWES diet supplemented
with docosahexaenoic acid (DHA) for 3 months had similar
thickeningof thecranial left ventricular (LV)wall comparedwith
rats fed a WES diet alone and had increased caudal LV wall
thickness compared with control (CON) animals [3]. These
findings led us to consider whether the underlying genotype of
themyocardial tissuediffereddespite a similar grossphenotype,
that is, whether WES diet consumption promoted a pathologic
ormaladaptive gene expressionprofile,whereasDHA treatment
was associated with physiologic or adaptive gene expression.
Transcriptome profiling in rats has distinguished unique
expression patterns in physiologic (adaptive) and pathologic
(maladaptive)myocardial hypertrophy, specifically in relation to
apoptosis, carbohydrate metabolism, and protein synthesis [8].
In addition, distinct myocardial expression patterns are associ-
atedwith diet inmice [9] and specifically with n-3 PUFA, evident
in a study of neonatal rat cardiomyocytes [10]. Incubation of
these cells with n-3 PUFA revealed differential expression of
genes associatedwith lipidhandling, inflammation, cell survival
and proliferation, extracellular matrix remodeling, calcium
handling, and oxidative stress [10]. Effects of one-time oral
administration of single fatty acids on the myocardial tran-
scriptome invivohavebeendocumented [11]. To further develop
ourknowledgeusinga systemrelevant tohumans,weexamined
outcomes in response to prolonged oral intake of a combination
of fatty acids reflecting that consumed bypeople, using anormal
(without genetic aberrancy or induced pathology) rat model.
Our objective was to determine whether long-term DHA
supplementation of aWES diet alters gene expression in the rat
left ventricle and whether the expression patterns reflect a
physiologic or pathologic response. To answer this question,
microarray transcriptome profiling was used to uncover
changes in gene expression associatedwith dietary treatments,
followed by quantitative real-time polymerase chain reaction
(qRT-PCR), and immunoblotting to validate and further pursue
relevant gene pathways. We hypothesized that WES diet
consumption would be associated with a pathologic or mal-
adaptive gene expression profile, whereas DHA treatment
would favor a physiologic or adaptive expression pattern.2. Methods and materials
A previously reported dietary study includes information
regarding animals, dietary treatments, anesthesia, and tissuecollection [3]; brief summaries are provided below. Left
ventricular tissue samples used in the present work were
taken from a subset of Wistar rats from this previously
reported dietary study examining the effect of diet and strain
(Sprague Dawley and Wistar). The Wistar strain is commonly
used for dietary studies, enabling broader comparison. In
addition, the Wistar strain was chosen due to an observed
interaction effect of diet and strain on systolic blood pressure;
consumption of the WES diet was associated with increased
systolic blood pressure in Wistar rats (177 ± 13 mm Hg) but
decreasedbloodpressure inSpragueDawley rats (117±6mmHg),
comparedwith CON groups (138 ± 6mmHg and 150 ± 10mmHg,
respectively; interaction, P < .001).
2.1. Animals
This study was approved by The Colorado State University
Institutional Animal Care and Use Committee. The protocols
and conditions meet the standards described in the Animal
Welfare Act regulations, the Guide for the Care and Use of
Laboratory Animals, and the Guide for the Care and Use of
Agricultural Animals in Agricultural Research and Teaching.
Male Wistar rats (Charles River Laboratories, Wilmington,
MA, USA) were maintained in a temperature- and humidity-
controlled environment in the Colorado State University
Laboratory Animal Resource Center. Rats were housed in
pairs and maintained in a normal 12-hour light/12-hour dark
cycle. Before initiation of dietary treatments, the rats were
allowed a 2-week acclimation period.
2.2. Diet
Diet macronutrient and fatty acid composition as well as
ingredients are listed in Table 1. A WES diet is composed of
increased saturated fats and simple carbohydrates and a high
(10:1-30:1) ratio of n-6:n-3 PUFA. Compared with the CON diet,
our WES diet reflected these differences. In addition, the WES
diet was composed of simple (sucrose) and complex (cellulose)
carbohydrates, whereas the CON diet contained only complex
(cellulose and cornstarch) carbohydrates. The diets were
supplied by Harlan Teklad (Madison, WI, USA). The DHA in the
diets, incorporated during manufacturing, was in the form of
microalgae-derived DHASCO oil (Martek, Columbia, MD, USA).
At age 6 weeks, the rats were divided into 1 of 3 dietary
treatment groups (n = 10): CON, WES, and Western +
docosahexaenoic acid (WES + DHA). Previous work revealed
that male Wistar rats fed PUFA-enriched diets had stable
myocardial fatty acid compositions after 2 months of treat-
ment [12]. A dietary treatment duration of 12 weeks was used
in an effort to produce LVH while limiting the development of
comorbidities. Food intake and body weights were measured
twice weekly. Rats were fasted overnight before terminal
sample collection.
Table 1 – Dietary macronutrient, fatty acid composition, and ingredient composition of individual diets
Macronutrient CON WES WES + DHA
Protein % kJ 16.4 16.4 16.4
Carbohydrate % kJ 72.8 25.8 25.8
Fat % kJ 10.8 57.9 57.9
Saturated fat % total fatty acids 48.0 69.0 69.0
Monounsaturated fat % total fatty acids 21.0 21.0 21.0
Polyunsaturated fat % total fatty acids 31.0 10.0 10.0
KJ/g 15.06 18.83 18.83
n-6 % total diet 0.67 2.88 1.7
n-3 % total diet 0.58 0.14 1.4
n-6:n-3 1.2 21.0 1.2
Macronutrient composition for rat diets. doi:10.1371.pone.0051994.t001
FA CON WES WES + DHA
8:0 2.5 3.8 3.6
10:0 2.0 3.0 3.0
12:0 12.5 19.4 18.9
14:0 7.0 10.6 11.5
16:0 13.8 17.3 17.2
18:0 8.9 11.4 10.7
18:1 n-9 19.3 19.0 19.4
18:2 n-6 (LA) 16.3 9.9 5.8
18:3 n-3 (ALA) 14.3 0.5 0.5
22:6 n-3 (DHA) 0.0 0.0 4.4
Individual fatty acid composition of diets shown as % of total dietary fatty acids
Ingredients CON WES WES + DHA
Casein (g/kg) 165 210 210
DL-Methionine (g/kg) 2.2 3 3
Corn starch (g/kg) 549.79
Maltodextrin (g/kg) 145 145 145
Sucrose (g/kg) 130.5 130.5
Cellulose (g/kg) 50 155.36 155.36
Safflower oil (linoleic) (g/kg) 5.5 20 5
Coconut oil, hydrogenated (g/kg) 10 110 104
Anhydrous milk fat, Butterfat (g/kg) 10 105 99
Flaxseed oil (g/kg) 10.5
Lard (g/kg) 5 45 42
Soybean oil (g/kg) 10 10
DHA oil (DHASCO, 40% DHA) (g/kg) 30
Mineral Mix, AIN-93M-MX (94049) (g/kg) 35
Mineral Mix, AIN-93G-MX (94046) (g/kg) 49 49
Vitamin Mix, AIN-93-VX (94047) (g/kg) 10 14 14
Choline bitartrate (g/kg) 2 3 3
TBHQ (antioxidant) (g/kg) 0.01 0.04 0.04
Orange food color (g/kg) 0.1
Yellow food color (g/kg) 0.1
Abbreviations: FA, fatty acid; LA, linoleic acid; ALA, alpha linolenic acid; DHA, docosahexaenoic acid.
CON: omission of sucrose is an intentional feature of this CON diet. WES: orange food coloring added. WES+DHA: Yellow food coloring added.
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A commercial rodent anesthesia chamber was used for
induction. Anesthesia was induced and maintained using 4%
isofluorane in a 95% oxygen/5% carbon dioxide mixture. A
surgical plane of anesthesia was confirmed when a toe pinch
failed to elicit a change in respiratory rate or pattern.
2.4. Tissue collection
After exposure of the heart through a medial sternotomy, the
heart was excised, weighed, and immersed in ice cold saline.The left ventricle was isolated, snap frozen in liquid nitrogen,
and stored at −80°C.
2.5. Total RNA isolation
Total RNA was isolated from LV myocardial tissue using
TRIzol Reagent (Life Technologies, Grand Island, NY, USA),
followed by treatment with RNase-free DNase (QIAGEN,
Valencia, CA, USA). Sample RNA concentrationwas determined
using a NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA), and RNA integrity was
assessed using the Agilent 2100 Bioanalyzer (Agilent, Santa
Table 2 – Forward and reverse primer sequences used for qRT-PCR
Gene symbol Forward Tm Reverse Tm
Acot1 GTTTTGCCGTCATGGCTCTG 62.4 AGGCCAAGTTCACCCCCTTT 62.4
Akt2 GGATGAAGTCGCCCACACAG 64.5 GCTCCCGAGAGAGGTGGAAA 64.5
Ankrd23 GACGGGTCTTGGCCTGTTCT 64.5 ATGAGGTCCCAGGGGAAACA 62.4
Atp1a1 AACGGTTTCCTGCCCTTTCA 60.4 AGCCCACTGCACTACCACGA 64.5
Btg2 GGCTCCGGCTATCGCTGTAT 64.5 CGATGCGGTAGGACACTTCG 64.5
CA3 ATCGTGCCTGTTCCCTGCTT 62.4 GGGGGCTCATTCTCTGCACT 64.5
Ctgf GGGTGTGTGATGAGCCCAAG 58.5 ATGCCCATCCCACAGGTCTT 59.0
Ctsm TTGCACAATGGGGAGAATGG 60.4 GGCACGTTAACAGCCTGACG 64.5
Dnaja4 TGAAGGCATTGGTGGGAAGA 60.4 AGCGGTCCTTGGGGTTGATA 62.4
Dusp1 TTTTGTGTGGGTGGGTGGTC 62.4 ACCAACACTGGCTTCGTCCA 62.4
Flnc GGTCCCAGCAAGGCAGAGAT 59.6 CACCACAAAGGGGCTGTCTG 58.7
Gga2 CCTCCAGCCGTGATCTCTCA 64.5 GAGAAGTCAGGCGGTGCTCA 64.5
Gna12 CCGTGAAGGACACCATCCTG 64.5 CATGCAGGTGGCAGACACAC 64.5
Hsp90ab1 CTCAGGAACGCACGCTGACT 64.5 CCAAACTGCCCAATCATGGA 60.4
Keap1 GTGGCCAAGCAGGAGGAGTT 64.5 CAGCAGTGCCTGCACGTAGA 64.5
Kcnip2 CAAGAACGAATGCCCCAGTG 62.4 GAGCCATCGTGGTTGGTGTC 64.5
Mgc109340 TCCACCAAAAGCAACGCTGT 60.4 CCTTGAGACCGTGTCCATCG 64.5
Myh7 GCTGGAGCTGATGCACCTGT 64.5 ACAAAGTGAGGGTGCGTGGA 62.4
Pik3c2g CCCGGAAGAGGGATGATGAC 64.5 GGTGCTCGACATGGAGGTTG 64.5
Pptc7 TGCGAACATGTGAGCGGTTA 60.4 ATGCAGGCTGTGCTGCTACC 64.5
Rab1b TCTGCGGTTTGCTGATGACA 60.4 TCCTGAACCGTTCCTGACCA 62.4
Rcan1 CTCCCTGATTGCCTGTGTGG 64.5 TTCGGACACGCTTGAAGCTC 62.4
Rcn1 CCCGAGGACAACCAGAGCTT 64.5 CAAGGCCGTCTCCATCACTG 64.5
Retsat TCCATTCTGCCGAGCGTCTA 62.4 GGTGGTATGGCTGGGGGTTA 64.5
S-100a9 CGGCACGAGCTCCTTAGCTT 64.5 CGCCTTGTTCAGGGTGTCAG 64.5
Scn5a CTGGGCCTTCCTTGCACTCT 64.5 CCACCACAGCCAGGATCAAG 64.5
Slc6a6 GTGTGGATCGACGCTGGAAC 64.5 GGCATCCCAGCAGCATACAG 64.5
Slc31a1 GGGCTTGGGAGAAGTCCAGA 64.5 TCCTCATGTGGTCCGAAGGA 62.4
Sox4 AAACGCTGGAAGCTGCTCAA 60.4 TTCTCCCCAGGTTTGGCTGT 62.4
Spg7 GGTTGGCTGCTGGAACACAC 64.5 CATGCACATCCGCTCAAACA 60.4
Tns1 CACGGGTGTTGCCAGAAGAC 64.5 CATGAGTGGCTGGTGCACTG 64.5
Tram1 TCGGAGGTGGAGGGAACATT 62.4 AGGAGAGTCGGCTCCATTCG 64.5
Ube2g2 GAAGAGGCTGATGGCCGAAT 62.4 GCGGGGAAAACACCAAACTC 62.4
Rn18s GAGGCCCTGTAATTGGAATGAG 62.7 GCAGCAACTTTAATATACGCTATTGG 61.4
Gapdh CCAGGGCTGCCTTCTCTTGT 64.5 TGATGGGTTTCCCGTTGATG 60.4
Abbreviations: Akt2, v-akt murine thymoma viral oncogene homolog 2; Ankrd23, ankyrin repeat domain 23; Atp1a1, ATPase, Na+/K+ transporting, α 1
polypeptide; Dnaja4, DnaJ (Hsp40) homolog, subfamily A, member 4; Dusp1, dual-specificity phosphatase 1; Flnc, filamin C, γ; Gga2, golgi-associated,
γ adaptin ear, ARF-binding protein 2; Gna12, guanine nucleotide-binding protein (G protein) α 12; Hsp90ab1, heat shock protein 90 kd α (cytosolic), class B
member 1; Kcnip2, Kv channel-interacting protein 2; Myh7, myosin, heavy chain 7, cardiac muscle, β; Pptc7, PTC7 protein phosphatase homolog
(Saccharomyces cerevisiae); Rab1b, RAB1B, member RAS oncogene family; Rcan1, regulator of calcineurin 1; Rcn1, reticulocalbin 1, EF-hand calcium-binding
domain; Scn5a, sodium channel, voltage-gated, type V, α subunit; Slc31a1, solute carrier family 31 (copper transporters), member 1; Spg7, spastic paraplegia 7
(pure, complicated autosomal recessive); Tram1, translocation-associated membrane protein 1; Ube2g2, ubiquitin-conjugating enzyme E2G 2; Rn18s, 18s
ribosomal RNA; Gapdh, glyceraldehyde 3-phosphate dehydrogenase; Tm, melting temperature.
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between 1.9 and 2.1 and RNA integrity number (RIN) values
within a range of 8.5 to 10.0. Isolated RNA was stored at −80°C.
2.6. Microarray experimental design
The Affymetrix Rat 230 2.0 GeneChip (Affymetrix, Santa Clara,
CA, USA) was used in this experiment. A total of 31099 probe
sets are represented on this array. For each of the 3 dietary
treatments, there were 2 pooled samples of heart tissue (with
each pooled sample representing 5 rats) for a total of 6 arrays.
As we were interested in revealing differences between
treatment groups, we used pooled samples to reduce variabil-
ity between animals within a group [13]. Starting with 5 μg of
total RNA, according to the Affymetrix protocol, a Poly-A CON
spike-in was added to the sample followed by first-strand
complementary DNA (cDNA) synthesis, via reverse transcrip-tion, using a T7-Oligo(dT) promoter primer (QIAGEN, Valencia,
CA, USA), per manufacturer’s instructions. RNase H-mediated
second-strand synthesis was followed by cDNA purification,
and in vitro transcription reaction was carried out in the
presence of T7 RNA Polymerase (QIAGEN, Valencia, CA, USA)
and a biotinylated nucleotide analog/ribonucleotide mix for
complementary RNA (cRNA) amplification and labeling. The
biotinylated cRNA targets were then purified using provided
columns, fragmented and prepared for overnight hybridiza-
tion onto the probe arrays.
Biotinylated targets were purified from RNA samples for
hybridization to GeneChip Rat Genome 2.0 probe arrays using
the Affymetrix 3’ One-Cycle Target Labeling Kit. During target
preparation, double-stranded cDNA was synthesized from
total RNA, followed by an in vitro transcription reaction to
produce biotin-labeled cRNA. The cRNA was then fragmented
and hybridized to the GeneChip probe array, which was
21 7
WES vs. CON W+D vs. CON
W+D vs. WES
1
Fig. 1 – Venn diagram of differentially expressed probe sets
identified by microarray analysis (P ≤ .001).
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Scanning system (Affymetrix).
The hybridization cocktail was prepared using Affymetrix
reagents and added to the fragmented target samples,
including probe CONs. The sample mixture was then injected
into the probe array and hybridized at 45°C overnight for
16 hours.After targethybridization,probewashingandstaining
with streptavidin-phycoerythrin, biotinylated, antistreptavidin
antibody was performed using the automated GeneChip
Fluidics Station 450 (Affymetrix). After wash and stain, the
probe arrays were scanned using the GeneChip 3000 Array
Scanner with primary analysis by GCOS software (Affymetrix).
The data discussed in this publication have been deposited in
National Center for Biotechnology Information (NCBI) Gene
Expression Omnibus [14] and are accessible through GEO Series
accession number GSE52603 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE52603).
2.7. Pathway analysis
Probe sets with statistically significant differences for one or
more comparisons (P ≤ .001; fold change [FC], ≥1.74) were
examined further for the presence of overrepresented path-
ways using Ingenuity Pathway Analysis (http://www.
ingenuity.com/) (Ingenuity Systems, Inc., Redwood City, CA,
USA) software. For Ingenuity analysis, the default settings
were used, and the Affymetrix Rat 230 2.0 GeneChip platform
selected. Genes in pathways relevant to cardiac pathology
were selected for validation using qRT-PCR.
2.8. Primer design and validation
Quantitative real-time polymerase chain reaction was used to
validate a subset of differentially expressed genes (DEGs)
after microarray analysis. Gene-specific primers were de-
signed using the Primer3 program (http://frodo.wi.mit.edu/)
(Massachusetts Institute of Technology, Cambridge, MA,USA). Primer design criteria included a base-pair length of
125 to 175 and a guanine-cytosine (GC) content of 40% to
60%. Primers were designed to span exon/intron boundaries
where possible and were tested using the same cDNA sample
pool, to ensure that there was no genomic contamination.
Primer pair sequences are provided in Table 2. An initial screen
was performed to validate 18s ribosomal RNA (Rn18s) and
glyceraldehyde 3-phosphate dehydrogenase (Gapdh) as internal
CON genes; both were selected based on their presence in the
tissues (crossing point [Cp], <35), and relative levels were not
affected by treatment (SD, <1.0 between all samples).
Primer specificity was confirmed based on polymerase
chain reaction (PCR) amplification of a single amplicon
followed by sequencing of the amplicons. The PCR cycle
conditions were as follows: 95°C for 5 minutes, followed by 40
cycles at 95°C for 15 seconds, 60°C for 30 seconds, and 72°C for
15 seconds. Before quantitative analysis, PCR amplification
efficiencies were determined by generating standard curves
based on 10-fold serial dilutions of cDNA generated from
pooled myocardial RNA. Efficiencies were 90% to 110% for
primers used in qRT-PCR.
2.9. Complementary DNA synthesis
Messenger RNA was reverse transcribed into cDNA using a
Quanta Biosciences cDNA Synthesis kit (Quanta Biosciences
Inc, Gaithersburg, MD, USA) according to manufacturer’s
instructions. Approximately 1 μg of total RNA was reverse
transcribed, and resulting cDNA was quantified using the
NanoDrop ND-1000 Spectrophotometer to ensure equivalent
concentrations for real-time analysis.
2.10. Quantitative real-timepolymerase chain reactionanalysis
Real-time PCR analysis was performed using SYBR Green
(Roche Applied Science, Indianapolis, IN, USA). Each 10 μL
reaction contained 2X SYBR Green Master Mix I, 0.5 μmol/L
gene specific forward and reverse primers, and 100 ng cDNA.
Polymerase chain reaction analysis was accomplished using
the LightCycler480 PCR System (Roche Applied Science) with
the following cycle conditions: 95°C for 5 minutes followed by
45 cycles of 95°C for 10 seconds, 60°C for 30 seconds, and 72°C
for 30 seconds. A melt curve analysis confirmed the amplifi-
cation of a single cDNA product.
2.11. Protein isolation
Approximately 0.05 g of rat LV tissue was pulverized under
liquid nitrogen, followed by lysis and homogenization
using a rotor/stator-type homogenizer. The homogeniza-
tion buffer contained 20 mmol/L 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) (pH 7.4), 1% Triton
X-100, 10% glycerol, 2 mmol/L ethylene glycol tetraacetic
acid (EGTA), 1mmol/L sodiumvanadate, 2mmol/L dithiothreitol,
1 mmol/L phenlymethysufonal fluoride, 50 mmol/L β-
glycerophosphate, 3 mmol/L benzamide, 10 μmol/L leupeptin,
5 μmol/L pepstatinA, and 10 μg/mL aprotinin. After collection of
the supernatant, protein was quantitated using the Biuret
method, and 2.5 μg/μL aliquots of protein homogenates were
stored at −20°C for use in Western blot (WB).
Table 3 – Differentially expressed genes according to microarray analysis and analyzed by qRT-PCR and WB
Gene symbol Probe set ID Gene title Microarray
log2 FC
Microarray P
value
Microarray
directionality
WES vs CON
CA3 1367896_at Carbonic anhydrase III, muscle specific 1.738 4.29 × 10−5 ↑ W v Ca,b
Pik3c2g 1369050_at Phosphatidylinositol-4-phosphate 3-kinase, catalytic type 2 γ 0.913 2.29 × 10−3 ↑ W v C a
Rcn1 1375921_at Reticulocalbin 1, EF-hand calcium-binding domain −0.912 4.69 × 10−4 ↓ W v Ca
Retsat 1370806_at Retinol saturase (all-trans-retinol 13,14-reductase) −0.833 1.43 × 10−3 ↓ W v C a
S-100a9 1387125_at S-100 calcium-binding protein A9 0.957 1.94 × 10−4 ↑ W v C
WES + DHA vs CON
Acot1 1398250_at Acyl-CoA thioesterase 1 1.481 3.62 × 10−6 ↑ D v C a,b
Akt2 1368832_at V-akt murine thymoma viral oncogene homolog 2 −1.076 5.86 × 10−4 ↓ D v C a
Akt2 1387353_at V-akt murine thymoma viral oncogene homolog 2 −0.883 5.47 × 10−4 ↓ D v C a
Ankrd23 1371927_at Ankyrin repeat domain 23 −0.869 4.40 × 10−4 ↓ D v C a
Atp1a1 1371108_a_at ATPase, Na+/K+ transporting, α 1 polypeptide −1.193 1.67 × 10−4 ↓ D v C a
Btg2 1386995_at BTG family, member 2 −0.939 9.36 × 10−4 ↓ D v C a,b
Ctgf 1367631_at Connective tissue growth factor −0.983 1.93 × 10−4 ↓ D v C a
Dnaja4 1395572_at DnaJ (Hsp40) homolog, subfamily A, member 4 −0.91 3.56 × 10−4 ↓ D v C a
Dusp1 1368147_at Dual-specificity phosphatase 1 −1.386 4.57 × 10−4 ↓ D v C a
Flnc 1396085_at Filamin C, γ −0.906 2.11 × 10−4 ↓ D v C a
Gga2 1395394_at Golgi-associated, γ adaptin ear, ARF-binding protein 2 −0.877 7.52 × 10−5 ↓ D v C a
Gna12 1369278_at Guanine nucleotide-binding protein (G protein) α 12 −1.401 8.10 × 10−4 ↓ D v C a
Hsp90ab1 1375335_at Heat shock protein 90 kd α (cytosolic), class B member 1 −0.843 3.62 × 10−4 ↓ D v C a
Kcnip2 1370773_a_at Kv channel-interacting protein 2 −1.045 7.95 × 10−4 ↓ D v C a
Keap1 1387810_at Kelch-like ECH-associated protein 1 −1.051 8.25 × 10−4 ↓ D v C c
Mgc109340 1373333_at Similar to microsomal signal peptidase 23 kd subunit 1.263 8.60 × 10−5 ↑ D v C c
Myh7 1367928_at Myosin, heavy chain 7, cardiac muscle, β −1.962 3.83 × 10−7 ↓ D v C a
Myh7 1386993_at Myosin, heavy chain 7, cardiac muscle, β −0.992 1.13 × 10−4 ↓ D v C a
Pik3c2g 1369050_at Phosphatidylinositol-4-phosphate 3-kinase, catalytic type 2 γ 1.961 1.14 × 10−5 ↑ D v C
Pptc7 1378246_at PTC7 protein phosphatase homolog (S cerevisiae) −0.851 8.74 × 10−4 ↓ D v C a
Rab1b 1385270_s_at RAB1B, member RAS oncogene family −1.086 2.25 × 10−4 ↓ D v C a
Rab1b 1393669_at RAB1B, member RAS oncogene family −1.107 6.00 × 10−4 ↓ D v C a
Rcan1 1388686_at Regulator of calcineurin 1 −0.888 2.77 × 10−4 ↓ D v C a
S-100a9 1387125_at S-100 calcium-binding protein A9 0.853 4.28 × 10−4 ↑ D v C
Scn5a 1388035_a_at Sodium channel, voltage-gated, type V, α subunit −0.978 8.68 × 10−4 ↓ D v C a
Slc6a6 1368778_at Solute carrier 6 (neurotransmitter transporter, taurine), 6 −0.929 3.92 × 10−4 ↓ D v C
Slc31a1 1368046_at Solute carrier family 31 (copper transporters), member 1 −0.812 4.64 × 10−4 ↓ D v C a
Tns1 1385704_at Tensin 1 −0.961 2.54 × 10−4 ↓ D v C c
Tram1 1390077_at Translocation-associated membrane protein 1 −0.811 7.33 × 10−4 ↓ D v C a
Ube2g2 1380157_at Ubiquitin-conjugating enzyme E2G 2 −0.88 2.90 × 10−4 ↓ D v C a
WES + DHA vs WES
Btg2 1386995_at BTG family, member 2 −0.814 2.27 × 10−3 ↓ D v W a
CA3 1367896_at Carbonic anhydrase III, muscle specific −1.43 1.75 × 10−4 ↓ D v W a,b
Ctsm 1391049_at Cathepsin M 0.93 7.04 × 10−4 ↑ D v W a
Gna12 1369278_at Guanine nucleotide-binding protein (G protein) α 12 −0.803 1.81 × 10−2 ↓ D v W a
Kcnip2 1370773_a_at Kv channel-interacting protein 2 −0.878 2.36 × 10−3 ↓ D v W a
Myh7 1367928_at Myosin, heavy chain 7, cardiac muscle, β −1.557 2.39 × 10−6 ↓ D v W a
Myh7 1386993_at Myosin, heavy chain 7, cardiac muscle, β −0.906 2.13 × 10−4 ↓ D v W a
Pik3c2g 1369050_at Phosphatidylinositol-4-phosphate 3-kinase, catalytic type 2 γ 1.047 9.80 × 10−4 ↑ D v W
Rab1b 1385270_s_at RAB1B, member RAS oncogene family −0.803 1.63 × 10−3 ↓ D v W a
Retsat 1370806_at Retinol saturase (all-trans-retinol 13,14-reductase) 0.984 4.88 × 10−4 ↑ D v W a
Sox4 1375123_at SRY (sex-determining region Y)-box 4 −0.915 3.79 × 10−4 ↓ D v W c
Spg7 1395985_at Spastic paraplegia 7 (pure, complicated autosomal recessive) −0.85 4.51 × 10−4 ↓ D v W a
Abbreviations: S cerevisiae, Saccharomyces cerevisiae; ID, identifier.
Differentially expressed genes according to microarray analysis, (P ≤ .001) and log2 FC at least 0.8 (equivalent to FC, ≥1.74), and analyzed by
qRT-PCR. Microarray values are shown as log FCs.
a Directional change same as qRT-PCR.
b Directional change same as WB.
c Directional change not determined via qRT-PCR due to low expression levels.
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Proteins (approximately 50 μg) were separated by molecular
weight using sodium dodecyl sulfate polyacrylamide gel
electrophoresis and transferred to a polyvinylidene fluoridemembrane. DEGs (P ≤ .001; FC, ≥1.74) relevant to either
nutritional/metabolic aberrancy or cardiovascular system
disease/function pathways that were chosen for WB analysis
included acyl-CoA thioesterase 1 (Acot1), B-cell translocation gene 2
(Btg2), carbonic anhydrase III (CA3), and retinol saturase (all-trans-
Table 4 – Top pathways and functions of the differentially
expressed transcripts analyzed by Ingenuity
Top canonical pathways P Ratio
WES vs CON
Nitrogen metabolism 3.01 × 10−3 1/32 (0.031)
WES + DHA vs CON
Sphingosine-1-phosphate
signaling
6.43 × 10−5 3/78 (0.038)
Relaxin signaling 1.2 × 10−4 3/99 (0.03)
Gα12/13 signaling 1.23 × 10−4 3/97 (0.031)
CXCR4 signaling 1.94 × 10−4 3/114 (0.026)
CREB signaling in neurons 2.05 × 10−4 3/117 (0.026)
WES + DHA vs WES
ILK signaling 8.74 × 10−4 2/143 (0.014)
Actin cytoskeleton signaling 1.09 × 10−3 2/161 (0.012)
Cardiomyocyte differentiation
via BMP receptors
5.77 × 10−3 1/16 (0.062)
Nitrogen metabolism 9.01 × 10−3 1/32 (0.031)
IL-9 signaling 9.72 × 10−3 1/27 (0.037)
Top tox lists P Ratio
WES + DHA vs CON
Renal necrosis/cell death 1.51 × 10−3 2/55 (0.036)
TR/RXR activation 2.23 × 10−3 2/67 (0.03)
p53 signaling 2.5 × 10−3 2/71 (0.028)
RAR activation 6.21 × 10−3 2/113 (0.018)
NRF2-mediated oxidative
stress response
1.01 × 10−2 2/145 (0.014)
WES + DHA vs WES
TR/RXR activation 2.4 × 10−2 1/67 (0.015)
p53 signaling 2.54 × 10−2 1/71 (0.014)
NRF2-mediated oxidative
stress response
5.15 × 10−2 1/145 (0.007)
Cardiac hypertrophy 7.6 × 10−2 1/216 (0.005)
Top bio functions P No. of
molecules
WES + DHA vs CON
Connective tissue disorders 1.08 × 10−3-1.08 × 10−3 1
Organismal injury
and abnormalities
1.08 × 10−3-2.68 × 10−2 2
Skeletal and muscular
disorders
7.56 × 10−3-7.56× 10−3 1
Cardiovascular disease 9.72 × 10−3-3.00× 10−2 2
Developmental disorder 2.78 × 10−2-3.00× 10−2 2
WES + DHA vs WES
Cardiovascular disease 7.57 × 10−3-1.01 × 10−2 1
Organismal injury
and abnormalities
7.57 × 10−3-9.01 × 10−3 1
Developmental disorder 1.01 × 10−2-1.01 × 10−2 1
Abbreviations: Gα12/13, G protein alpha 12/13; CXCR4, chemokine
(C-X-C motif) receptor-4; CREB, cyclic AMP responsive element
binding protein; BMP, bonemorphogenetic protein; TR/RXR, thyroid
receptor/retinoid x receptor; RAR, retinoic acid receptor; NRF2,
nuclear factor erythroid 2-related factor.
Transcripts identified by microarray analysis, P ≤ .001 and analyzed
using Ingenuity. Pathways relevant to cardiac pathology are included.
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(ab-100915; Abcam, Cambridge, MA, USA), BTG2 (sc-33775;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), CA3 (NBP1-
88229; Novus Biologicals, Littleton, CO, USA), and RETSAT
(NBP1-92325; Novus Biologicals) were used for each sample.
Each antibody was tested for specificity, and optimal concen-
trations (minimal background/nonspecific staining) were
determined before final immunoblotting. Western analysiswas performed using n = 10 samples from each group for
biological replicates.
Samples were run on at least 2 different gels and incubated
with the primary antibodies in at least 2 separate experi-
ments. Dilutions were as follows: ACOT1; BTG2, 1:1000; CA3,
1:1500; RETSAT, 1:1250. All membranes were blocked for
1 hour at room temperature, incubated with primary antibody
overnight at 4°C, and incubated with secondary antibody for
1 hour at room temperature. Blocking solution, primary
antibodies, and secondary antibodies were diluted in 5%
nonfat dried milk in 1X Tris Buffered Saline–Tween.
2.13. Statistical analyses
2.13.1. Microarray analysis
Statistical analysis of the array data was performed using the
R 2.11.0 and BioConductor (Fred Hutchinson Cancer Research
Center, Seattle, WA, USA) [15]. The Affymetrix CEL files were
imported into R, and a number of diagnosticswere considered.
These included examination of array images, boxplots of log2
perfect match values, present/absent calls by array, hybridi-
zation CON spots, and an RNA degradation plot. Preprocessing
(including background correction, normalization, and probe
set summaries) was performed using the robust multiarray
average algorithm [16].
Statistical tests of differential expression were conducted
using the moderated t test through the Linear Models for
Microarray package in BioConductor [17]. Estimates of log2 FC
(set at ≥0.8; equivalent to FC, ≥1.74) and corresponding P values
were calculated for each probe set and each comparison (WES
vs CON,WES +DHAvs CON, andWES +DHAvsWES). A P value
cut off of 0.001 was used to determine statistical significance.
The Benjamini-Hochberg [18] false discovery rate controlling
procedure was attempted; however, based on the small
numbers of DEGs, unadjusted P values proved a more
appropriate analysis (Table S1).
2.13.2. Quantitative real-time polymerase chain reaction analysis
Each primer pair was run in triplicate, and raw Cp values were
tested for variation within a sample and averaged. Expression
levels of all genes were determined by normalizing the raw Cp
values using the geometric mean (GM) of Rn18s and Gapdh as a
normalization factor. Relative levels are presented as the mean
Cp values relative to thenormalization factor (GM/averageCp) for
each treatment group. The data were analyzed using analysis of
variance (ANOVA), with statistical significance at P ≤ .05. The
least significant difference method for pairwise comparisons
was used when ANOVA revealed a difference among dietary
treatment groups.
2.13.3. Western analysis
Densitometry was conducted on all samples using α-tubulin
as a loading CON. Each blot was subjected to 3 separate
analyses; the averages were normalized against α-tubulin. All
results were tested for normality and equality of variance and
analyzed with one-way ANOVA, with blocking for gel effect,
using JMP (SAS, Cary, NC, USA) statistical software. Statistical
significance was set at P ≤ .05. The least significant difference
method for pairwise comparisons was used when ANOVA
revealed an effect of diet.
Table 5 –Western blot densitometry data
Protein Treatment Average ratio
(protein: α-tubulin)
ANOVA P
ACOT1 CON 0.5159 .430
WES 0.7290
WES + DHA 0.5865
BTG2 CON 0.1996 .858
WES 0.1736
WES + DHA 0.1770
CA3 CON 0.9587 .378
WES 1.2705
WES + DHA 1.042
Western blot results, n = 10 for each group. Results are normalized
with α-tubulin, and values are means ± SEM, P ≤ .05.
A
B
0.43
0.44
0.45
0.46
0.47
0.48
0.49
0.5
0.51
CON WES WES+DHA
R
el
at
iv
e 
Ex
pr
es
si
on
G
M
/A
vg
Cp
Ct
gf
 
*
0.44
0.45
0.46
0.47
0.48
0.49
0.5
0.51
0.52
0.53
0.54
CON WES WES+DHA
R
el
at
iv
e 
Ex
pr
es
si
on
G
M
/A
vg
Cp
Ct
sm
 
*
Fig. 2 – Relative mRNA expression in LV tissue according to
qRT-PCR. Values are expressed as the GM of the house-
keeping genes/average Cp values for each gene. Values are
means ± SEM; n = 10 for each group. A, Connective tissue
growth factor mRNA expression. ⁎P ≤ .05, WES + DHA
compared with CON and WES rats. B, Cathepsin M mRNA
expression. ⁎P ≤ .05, WES + DHA compared with WES rats.
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Abrief summary of previously publisheddata relevant to the
present study is provided in Table S2 (body weight, energy
intake, adiposity, LV weight, and serum metabolic indices).
Previously reported gas chromatography data confirm that
dietary DHAwas incorporated into the phospholipid fraction of
myocardial septal tissue (CON 13.79 ± 0.49 area %, WES 10.82 ±
0.43 area %, WES + DHA 31.64 ± 0.50 area %; P < .0001) [3].
3.1. Microarray analysis
Microarray analysis revealed 64 probe sets differentially
expressed (P ≤ .001) between one or more dietary treatments
groups (Fig. 1). Among the 64 differentially expressed probe
sets, 14 probe sets were unidentified. Of the identified
differentially expressed probe sets, with P ≤ .001, 33 exhibited
FC at least 1.74 (Table 3). There were 5 differentially expressed
probe sets between the WES vs CON dietary group, 27 probe
sets between the WES + DHA vs CON group, and 11 betweenWES + DHA vs WES treatment group. These probe sets were
subjected to further validation using qRT-PCR.
3.2. Pathway analysis
Pathwayanalysisusing Ingenuity PathwayAnalysis (Ingenuity
Systems, Inc), revealed top canonical pathways, toxicology
lists, and biological functions (Table 4). Represented canonical
pathways relevant to nonischemic cardiomyopathy included
sphingosine-1-phosphate signaling [19], relaxin signaling [20],
G protein alpha 12/13 (Gα12/13) signaling [21], and chemokine
(C-X-Cmotif) receptor-4 (CXCR4) signaling [22] (WES + DHA vs.
CON) aswell as integrin-linked kinase (ILK) signaling [23], actin
cytoskeleton signaling [24], and interleukin 9 (IL-9) signaling
[25,26] (WES + DHA vs WES). Toxicologic pathways relevant to
nonischemic cardiomyopathy included p53 signaling [27,28]
and nuclear factor, erythroid 2-related factor (NRF2)-mediated
oxidative stress response [29] (WES + DHA vs CON and WES +
DHA vs WES) as well as retinoic acid receptor (RAR) activation
[30,31] (WES + DHA vs CON) and cardiac hypertrophy (WES +
DHA vs WES). There were no toxicologic pathways that
emerged from the WES vs CON comparison. Top biological
functions relevant to cardiomyopathy included connective
tissue disorders and skeletal and muscular disorders (WES +
DHA vs CON) as well as organismal injury and abnormalities
and cardiovascular disease (WES + DHA vs CON and WES +
DHAvsWES). Therewere no biological functions that emerged
from the WES vs CON comparison.
3.3. Gene expression analysis by qRT-PCR
Of the 33 genes (P ≤ .001; FC, ≥1.74) validated by qRT-PCR, 4 genes
(kelch-like ECH-associated protein 1 [Keap1], similar to microsomal
signal peptidase 23 kd subunit [Mgc109340], SRY [sex-determining
region Y]-box 4 {Sox4}, and tensin 1 [Tns1]) were present at levels
too low (Cp, >35) to be reliably quantified. Two of the genes,
connective tissue growth factor (Ctgf) and cathepsin M (Ctsm), were
differentially present in LV tissue according to diet (Fig. 2).
Connective tissue growth factorwasdecreased inmyocardial tissue
of WES + DHA rats compared with CON and WES rats, whereas
Ctsmwas increased inWES +DHA rats comparedwithWES rats.
Relative expression of the remaining genes examined was not
statistically different according to diet; however, all of the genes
except phosphatidylinositol-4-phosphate 3-kinase, catalytic type 2 γ
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Fig. 3 – Retinol saturase (all-trans-retinol 13,14-reductase)
protein levels in LV tissue. Average values for each group
were normalized with α-tubulin. Results are shown as
means ± SEM; n = 10 for each group. A, Retinol saturase
(all-trans-retinol 13,14-reductase) was increased in WES rats
compared with CON and WES + DHA rats (⁎P ≤ .05). B,
Representative immunoblots for RETSAT.
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carrier 6 (neurotransmitter transporter, taurine), 6 (Slc6a6) exhibited
similar directional change to that observed by microarray
analyses (Table 3).
3.4. Immunoblot analysis
Myocardial gene expression of Acot1, Btg2, CA3, and Retsatwas
altered according to diet; however, immunoblot analysis
revealed that ACOT1, BTG2, and CA3 protein levels were not
different (Table 5). Retinol saturase (all-trans-retinol 13,14-
reductase) protein expression was increased in LV tissue from
WES rats compared with CON andWES + DHA animals (Fig. 3).4. Discussion
The aim of this studywas to characterize themolecular profile
of myocardial tissue after dietary fatty acid intake to better
understand unexpectedly similar phenotypes associated with
a WES diet and WES + DHA intake.[3] We previously reported
that WES and WES + DHA feeding were associated with
similarly increased LV cranial wall thickness and decreased
LV internal diameter during diastole, compared with CONanimals [3]. The present model is useful in that fat-fed rats do
not develop increased body weight or visceral adiposity,
hypertriglyceridemia, or systemic insulin resistance [3],
allowing for examination of diet effects in the absence of
these modulators of myocardial structure and function. The
absence of conventional comorbidities is probably due to
similar energy intake and feed efficiency across groups,
attributed to the large amount of dietary fat in both high-fat
diets and resultant reduced intake by weight. Furthermore,
compared with CON and WES animals, WES + DHA rats had
greater circulating adiponectin, an adipokine associated with
antihypertrophic effects [32-34]. The lack of improvement in
WES diet-associated gross LVH with supplemental DHA,
together with the diet effect on myocyte cross sectional area
and circulating adiponectin, led us to consider whether the
diets were associated with genotypic variation distinguishing
an adaptive vs maladaptive myocardial response.
4.1. Pathway analysis
Our results indicate that Wistar rats develop surprisingly few
differences in myocardial gene expression, despite the
interaction effect of diet and blood pressure previously
observed in this strain. Of the 3 possible group comparisons,
the CON vsWES dietary groups surprisingly revealed the least
genotypic variance. No canonical or toxicologic pathway was
strongly represented; the ratio of DEG:total pathway genes did
not exceed 0.038. Following is a more detailed discussion of
represented pathways and functions relevant to acquired
nonischemic cardiomyopathy initially identified in results,
with a focus on those specific to the WES vs WES + DHA
groups, identified as the principle comparison of the study.
Of canonical pathways, the ILK signaling pathway was
represented. Mice with cardiac ILK deletion developed dilated
cardiomyopathy, systolic dysfunction, fibrosis, and myocyte
disarray [23]. Actin cytoskeleton signaling was also identified
as differentially represented in WES and WES + DHA rats.
Cytoskeletal function is critical to cell stabilization, signal
transduction, and myocardial contraction; disruption of this
system is a known contributor to an array of hypertrophic and
dilative cardiomyopathic responses [35], and evidence sug-
gests that modulation of the actin cytoskeleton may be a
mechanism of leptin-associated myocardial remodeling [24].
The cytokine IL-9 was also identified as relevant to theWES vs
WES + DHA comparison; circulating levels are increased in
association with cardiomyopathy and heart failure [25,26].
Of the cardiomyopathy-associated toxicologic pathways
differentially represented in WES and WES + DHA groups, p53
signaling emerged. Inhibition of p53 activity has been associated
with reducedmyocardial expression ofmarkers of apoptosis and
proliferation with induced hypertrophy [27,28]; in addition, p53
appears to play a role in the transition fromhypertrophy to heart
failure by inhibiting angiogenesis [28]. The factor Nrf2 mediates
antioxidant responses, and when down-regulated is associated
with heart failure and unmitigated afterload-induced oxidative
stress [29]. Cardiac hypertrophy also emerged as a toxicologic
processdifferentially represented inWESandWES+DHAgroups.
Also relevant to these 2 treatment groups, biological func-
tions pertinent to acquired nonischemic cardiomyopathy in-
cluded cardiovascular disease and organismal injury and
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strated remarkable genotypic and phenotypic aberration with
WESandhigh-fatdiet intakebut in thepresenceof comorbidities
that are known to be associated with myocardial hypertrophy
(ie, increased bodyweight, hypertension, and insulin resistance)
[7,36,37]. Collectively, these data support the idea that diet,
unaccompanied by changes in body morphometry, hemody-
namics, ormetabolic aberrancy,may be aminor determinant in
the development of obesity-induced cardiomyopathy.
4.2. Selected differentially expressed factors relevant to
metabolic or cardiovascular aberrancy
A previous study using cultured neonatal rat cardiomyocytes
treated with eicosapentaenoic acid and DHA revealed 122
DEGs (FC, ≥0.51), 47 of which the authors were able to identify
[10]. In the present in vivo study, the WES + DHA vs CON
dietary groups revealed the largest number of DEGs. Following
is a brief discussion of 4 differentially expressed factors
relevant to either nutritional/metabolic aberrancy or cardio-
vascular system disease/function pathways that were vali-
dated by qRT-PCR and WB and altered by WES + DHA intake.
Retinol saturase (all-trans-retinol 13,14-reductase) encodes an
enzymethat is localized tomembranes andexpressedprimarily
inadipose, liver, kidney, and intestinal tissue [38,39] buthasalso
been identified in myocardial tissue.[40] The enzyme catalyzes
the saturation of all-trans-retinol to form all-trans-13,14-
dihydroretinol.[38] In vitro studies suggest that the enzyme
promotes adipocyte differentiation in a peroxisome prolifera-
tor-activated receptor (PPARγ)-dependent manner.[39] About
obesity, adipose Retsat messenger RNA (mRNA) is reduced in
both genetic and dietary murine models as well as in obese
humans, an effect partly attributed to suppression by infiltrat-
ing macrophages [39]. In the present study, myocardial Retsat
gene expressionwas reduced in rats fed theWES diet compared
with CON animals and increased with DHA supplementation.
Consistent with this, myocardial inflammation is enhanced
with WES diet intake [41] and attenuated by DHA [42]. In
contrast to gene expression, however, RETSAT protein expres-
sion was highest in WES-fed rats, suggesting that gene and
protein expression may be differentially regulated by diet and/
or inflammation. Should the apparently distinct protein re-
sponse in myocardium compared with adipose tissue be
observed in obese models, this may reflect the fact that the
myocardium is spatially removed from the adipose macro-
phages and local inflammatory milieu and thus is not as
susceptible to macrophage-associated suppression. In addition
to adipocyte differentiation, RETSAT appears to modulate
cellular resistance to oxidant injury, evidenced by the observa-
tion that Retsat expression was inversely related to protection
from peroxide-induced free radicals in cultured fibroblasts [43].
IncreasedRETSATprotein inWES-fed ratsmay reflect increased
susceptibility to oxidative injury; however, given the in vivo
model used in the present study, it is likely that any RETSAT-
induced modulation of this response would be modest com-
pared with that attributed to DHA [44,45] and WES diet [46]
consumption.
CA3 is a widely distributed enzyme that catalyzes the
hydrolysis of carbon dioxide to form H+ and HCO3−. A key
function is to increase carbon dioxide flux [47] out of cells andinto nearby capillaries, thus preventing acidosis and main-
taining physiologic intracellular pH [48]. Intracellular pH is
also regulated through the binding of CA with a bicarbonate
exchanger, which enhances transport activity [49]. Specific to
the myocardium, development of cellular or mitochondrial
acidosis can obtund contractility through an array of mech-
anisms, including reduced calcium availability and respon-
siveness as well as impaired energetics [50-52]. In contrast,
increased CAII and CAIV expression was measured in failing
myocardium, and it was proposed that increased CA-mediat-
ed activation of the Na+/H+ exchanger contributed to the
hypertrophic process through sustained increases in cytosolic
Ca2+ [53]. Carbonic anhydrase III is distinct in that it has low
carbon dioxide hydration activity compared with other iso-
zymes and acts as a phosphatase [54], possibly contributing to
free radical scavenging activity [55]. Relevant to isozyme
specificity,CAII,CA IV, andCAXIVare linked to thehypertrophic
response inmyocardial tissue [56,57],whereasCA3, the isozyme
altered in association with diet in the present study, is
distributed predominantly in skeletal muscle and liver [58]. As
CA3 is also localized to red blood cells [58], it is possible that
differences in CA3 expression observed in the present study
represent diet-associated alterations in circulating, rather than
myocardial, CA3. Should the observed expression profiles
reflectmyocardial tissue activity, the increased gene expression
in WES compared with CON rats and decreased expression in
WES +DHAcomparedwithWES rats, with similar directionality
in protein expression, may represent one factor contributing to
molecularly distinct hypertrophic responses.
Acyl-CoA thioesterases are PPAR-regulated enzymes that
promote the hydrolysis of long-chain acyl-CoAs to free fatty
acids and coenzymeA-SH, thus being important in cellular lipid
metabolism [59]. The isozyme,ACOT1, is localized to the cytosol
and regulated by PPAR-α [60].Acyl-CoA thioesterase 1 is increased
in the myocardium of rats fed a high-fat diet [60,61], an effect
proposed to attenuate aberrant mitochondrial fatty acid
oxidation andmitochondrial stress, thus preserving contractile
function [61]. Myocardial Acot1 and other fatty acid-responsive
genes were increased to a lesser extent in WES diet-fed rats
compared with high-fat fed animals, to which attenuated fatty
acid oxidation and contractile dysfunction were attributed [62].
Expression ofmyocardialAcot1 is partly determined by ingested
fatty acids, demonstrated in a study detailing the effect of a
single dose of isolated fatty acids inmice [11]. More specifically,
media enrichment with eicosapentaenoic acid and DHA
resulted in increased ACOT1 activity in cultured cells [63].
Consistent with this, increased Acot1 gene expression was
measured inWES + DHA–fed rats compared with CON animals,
and similar directionality of protein expression was observed;
this may represent an adaptive metabolic response underlying
myocardial protection attributed to DHA.
The family of Btg are studied primarily in relation to cancer,
due to antiproliferative effects attributable to cell cycle
regulation [64,65]. B-cell translocation gene 2 has been detected
in myocardial tissue in swine, where it appears to have a role
in normal development [66]. Whether it plays a role in
myocardial hypertrophy, where myocytes increase in size
rather than number is unknown. In addition to effects on
proliferation and development, BTG2 also protects human
mammary epithelial cells from oxidative stress [67]. It is
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similar mechanism. Interestingly, Btg2 gene expression was
decreased in WES + DHA rats compared with both CON and
WES animals, and in the former comparison, similar trends in
protein expression were observed. This suggests that the
antiproliferative and oxidant protective effects attributed to
BTG2 are not mechanisms of DHA-mediated cardioprotection.
4.3. Adaptive and maladaptive hypertrohpy
A comparison of myocardial gene expression relevant to
adaptive and maladaptive hypertrophy was conducted using
exercise-trained and Dahl salt-sensitive rats, respectively.[8]
At 6 months, changes in heart weight and myocardial
structure/function were more pronounced than in the
present study. Compared with CON animals, Dahl salt-
sensitive rats displayed differences in genes relevant to
apoptosis, whereas exercise-trained animals displayed dif-
ferences in genes associated with glucose and insulin
regulation as well as protein synthesis. Genes known to be
up-regulated with pathologic hypertrophy, atrial natriuretic
factor, and brain natriuretic protein were also increased in
the Dahl salt-sensitive rats. These trends were not observed
in the present study, and relatively few genes in a given
canonical or toxicologic pathway or biologic functional
grouping were differentially expressed. Taken together,
these results suggest that moderate duration dietary treat-
ment alone does not contribute to the development of a
conventional adaptive or maladaptive myocardial response,
thus the hypothesis is rejected.
4.4. Limitations
Study limitations include a relatively short duration of
treatment in young rats; more robust differences might be
observed with prolonged dietary treatment and/or use of
older animals. In addition, the rats in the present study
were not insulin resistant or dyslipidemic nor did they have
greater visceral adipose mass; the presence of these
comorbidities would likely reveal greater myocardial pa-
thology. Finally, hearts were not perfused; thus, the
presence of blood in tissue homogenates may have con-
founded gene and protein data.5. Conclusions
In summary, 3 months of WES diet and DHA consumption, in
the absence of altered body weight or adiposity, hypertension,
or systemic insulin resistance, led to surprisingly few DEGs in
the myocardium of normal rats. These results suggest that
dietary compositionmay not be as important a determinant of
cardiomyopathic change as that of resultant alterations in
morphometry, afterload, and metabolism. Four genes and/or
proteins relevant to either nutritional/metabolic aberrancy or
cardiovascular disease/function were differentially expressed
according to DHA consumption and may warrant further
characterization in response to long-termdietary treatment in
vivo. Furthermore, investigation of dietary treatment com-
bined with isolated comorbidities would better characterizethe relative contribution of each to development of cardio-
myopathy in obese individuals.
Supplementary data to this article can be found online at
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